Invitation to presentation of Xbrane Biopharma’s interim report January – March 2024 on May 16, 2024

Corporate Information





Xbrane Biopharma AB invites to a teleconference for investors, analysts and media on Thursday, May 16th, 2024, at 09.00 a.m. CET. Xbrane will publish the company’s interim report January – March 2024, on Thursday, May 16, 2024, at 8.00 a.m. CET.

Martin Åmark, CEO, and Anette Lindqvist, CFO/IR, will present the interim report January – March 2024, followed by a Q&A session. The presentation will be in English. To attend, please follow the link below:

If you wish to participate via webcast, please use the link below. Via the webcast you can ask written questions.

Xbrane Biopharma Q1 Report 2024 (

If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.

Call Access (